Evaluation of the Efficacy and Safety of a Dual Delayed-Release Formulation of 10-mg Esomeprazole in Patients with Gastric Erosions: A Multicenter, Randomized, Double-Blind, Active-Control, Phase III Study

Background/Aims : Clinical data on the efficacy and safety of the dual delayed-release formulation of 10-mg esomeprazole (HIP2101) are currently limited. Therefore, this study compared the efficacy and safety of HIP2101 and 20-mg famotidine (RLD2101) in patients with gastric erosions. Methods : In t...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Hyun Lim, Ju Yup Lee, Yong Hwan Kwon, Hee Seok Moon, Jong Kyu Park, Ki Bae Kim, Sang Wook Kim, Young Hoon Youn, Sang Gyun Kim, Gwang Ha Kim, Ji Won Kim, Jae-Young Jang, Kye Sook Kwon, Joong Goo Kwon, Hyun-Soo Kim, Su Jin Hong, Kwang Jae Lee, Suck Chei Choi, Jeong Seop Moon, Nayoung Kim, Jong-Jae Park, Yirang Lim, Sung Hee Hong, Hwoon-Yong Jung
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Gastroenterology Council for Gut and Liver 2025-07-01
Σειρά:	Gut and Liver
Θέματα:	proton pump inhibitors; hip2101; esomeprazole; gastritis; rld2101
Διαθέσιμο Online:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl240390
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!